BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
+28.61%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$494M
AUM Growth
+$494M
(+15%)
Cap. Flow
+$44.5M
Cap. Flow
% of AUM
9%
Top 10 Holdings %
Top 10 Hldgs %
67.93%
Holding
24
New
3
Increased
11
Reduced
4
Closed
3
Top Buys
| 1 |
Viking Therapeutics
VKTX
|
$25.5M |
| 2 |
Tarsus Pharmaceuticals
TARS
|
$22.1M |
| 3 |
Cigna
CI
|
$15.4M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
$13.2M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$12.7M |
Top Sells
| 1 |
Amgen
AMGN
|
$29.2M |
| 2 |
CVS Health
CVS
|
$29M |
| 3 |
BridgeBio Pharma
BBIO
|
$17.8M |
| 4 |
Danaher
DHR
|
$10.7M |
| 5 |
Viatris
VTRS
|
$9.3M |
Sector Composition
| 1 | Healthcare | 80.41% |
| 2 | Financials | 11.12% |
| 3 | Materials | 5.51% |
| 4 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Unum
UNM
$11.9B
| $55M | 11.12% | 1,025,027 +63,366 | +7% | +$3.4M |
|
|
2
Cigna
CI
$80.3B
| $47.9M | 9.69% | 131,926 +42,286 | +47% | +$15.4M |
|
3
Molina Healthcare
MOH
$9.8B
| $35.2M | 7.12% | 85,716 +17,428 | +26% | +$7.16M |
|
4
Enovis
ENOV
$1.77B
| $35.1M | 7.11% | 562,739 | – | – |
|
5
Baxter International
BAX
$12.7B
| $29.8M | 6.03% | 697,957 +149,421 | +27% | +$6.39M |
|
6
Globus Medical
GMED
$8.27B
| $28.4M | 5.75% | 529,825 | – | – |
|
|
BERY
7
DELISTED
Berry Global Group, Inc.
BERY
| $27.2M | 5.51% | 450,101 +218,645 | +94% | +$13.2M |
|
8
Amphastar Pharmaceuticals
AMPH
$1.42B
| $26.6M | 5.39% | 606,688 +206,688 | +52% | +$9.08M |
|
|
9
Viking Therapeutics
VKTX
$3.04B
| $25.5M | 5.15% | +310,462 | New | +$25.5M |
|
|
10
Bio-Rad Laboratories Class A
BIO
$8.06B
| $25M | 5.06% | 72,344 +36,631 | +103% | +$12.7M |
|
11
IDEAYA Biosciences
IDYA
$2.15B
| $23.3M | 4.72% | 531,967 | – | – |
|
|
12
Tarsus Pharmaceuticals
TARS
$2.47B
| $22.1M | 4.48% | +609,104 | New | +$22.1M |
|
|
13
Danaher
DHR
$147B
| $16.4M | 3.32% | 65,811 -42,690 | -39% | -$10.7M |
|
14
Mesa Laboratories
MLAB
$373M
| $14.6M | 2.96% | 133,394 +69,330 | +108% | +$7.61M |
|
15
Orthofix Medical
OFIX
$592M
| $14.1M | 2.86% | 974,502 +474,502 | +95% | +$6.89M |
|
|
16
Viatris
VTRS
$12.3B
| $13.5M | 2.74% | 1,133,591 -778,681 | -41% | -$9.3M |
|
17
Xenon Pharmaceuticals
XENE
$2.98B
| $12.5M | 2.54% | 291,403 +35,971 | +14% | +$1.55M |
|
18
Healthcare Services Group
HCSG
$1.13B
| $11.6M | 2.34% | +926,455 | New | +$11.6M |
|
19
Mirum Pharmaceuticals
MIRM
$3.71B
| $11.4M | 2.3% | 451,898 -38,241 | -8% | -$961K |
|
20
Pennant Group
PNTG
$830M
| $11.1M | 2.24% | 564,192 +234,532 | +71% | +$4.6M |
|
21
Quanterix
QTRX
$211M
| $7.78M | 1.57% | 330,151 -238,393 | -42% | -$5.62M |
|
|
22
BridgeBio Pharma
BBIO
$9.89B
| – | – | -440,845 | Closed | -$17.8M |
|
|
23
CVS Health
CVS
$92.8B
| – | – | -367,370 | Closed | -$29M |
|
|
24
Amgen
AMGN
$155B
| – | – | -101,508 | Closed | -$29.2M |
|